MEMS and Nanotechnology Providing Real Solutions for the Management of Diabetes
Complete the form below to unlock access to ALL audio articles.
During the first half of 2006, there was a noticeable upswing in activity focused on the development of MEMS and Nanotechnology-based solutions for the care and management of Diabetes, according to Bourne Research.
The market research firm reports that a variety of MEMS devices, nanostructures and other emerging technologies are not only being tapped for blood glucose monitoring and insulin delivery, but for other Diabetes-related complications as well, including those related to the eyes and gastrointestinal tract.
"What’s most notable about the current round of products in development, in clinical trials, or recently approved by the FDA and launched into the market is that many are wireless, implantable or both," says Marlene Bourne, President & Principal Analyst with Bourne Research.
"While these approaches will make living with and managing Diabetes much easier, they also highlight a very real need for next-generation battery technologies, which are in development."
Bourne Research reports that even though a few large firms dominate the Diabetes market, it remains very attractive for start-ups with innovative ideas, since this segment has historically been at the forefront of acquisition activity.
The firm notes that five companies have received nearly $80 million in venture capital funding in the past few months, and an acquisition is pending.
More details about the use of MEMS and Nanotechnology for the management of Diabetes can be found in The Bourne Report - Medical Device Quarterly, a report series written especially for those interested in BioMEMS and Nanomedicine.
The Bourne Report offers the most insightful analysis available on emerging technologies, with a focus on MEMS and Nanotechnology.
